EHRA 2023: Late-Breaking Science Video Collection

Published: 18 April 2023

  • Views:

    Views Icon 2345

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice. 

More from this programme

Part 1

Expert Interviews

7 sessions
POTTER: Oesophageal Fistulae in Catheter Ablation Patients Watch now
AdaptResponse: AdaptivCRT® Algorithm in Synchronized LV Pacing Watch now
MANIFEST-PF: Real-world Experience of PFA in Commercial Practice Watch now
ANTWOORD II: LVEF Recovery After Atrial Fibrillation Ablation in Heart Failure Patients Watch now
TEMPO-HCM: Extended ECG Monitoring in HCM Watch now
Conformable PVI Catheter for Pulmonary Vein Isolation Watch now
BRUGADA Randomized: Epidcardial Ablation to Prevent Sudden Death Watch now

Part 2

Featured Highlights

In these concise overviews, selected faculty provide their thoughts on the most impactful trials from EHRA 2023. 

2 sessions
5 Trials That Will Change Your Practice With Dr Sohaib Watch now
4 Trials That Will Change Your Practice With Dr Di Biase Watch now

Part 3

Behind the Heart

Watch our Behind the Heart series to learn more about the personal perspectives of the investigators behind top trials in cardiovascular science.

5 sessions
Dr Bergonti: Pulsed-Field Ablation & Reasons to Research Watch now
Dr Bruce Wilkoff: Therapy Morbidity and Advice to Young Researchers Watch now
Dr Carlo Pappone: Advice to Early-Career Electrophysiologists Watch now
Dr Juan Caro Codon: Building a Team For Success Watch now
Dr Vivek Reddy: Pulsed-Field Ablation’s Transformative Impact and Advice For Young Researchers Watch now

About the episode

EHRA 23 - In this short interview, Prof Roland Tilz (University Heart Centre Lübeck, DE) outlines the findings from the POTTER registry. 

The POTTER Registry (NCT05273645) gathered data on patients undergoing pulmonary vein isolation (PVI) with a rare complication, atrio-oesophageal fistula (AOF). The registry focuses on the incidence, diagnosis and management of this complication, which affects around 0.016-0.07% of PVI patients. Prof Tilz outlines the patient population, key findings and future prospects of this worldwide, multicenter, retrospective registry. 

Questions:
1. What was the rationale behind the creation of this registry?
2. What was the patient population and registry design?
3. What were the key findings?
4. How should these findings inform and shape practice?

A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study

Recorded on-site at EHRA 2023, Barcelona.

Editor: Jordan Rance

Faculty Biographies

Roland R Tilz

Roland R Tilz

Prof Roland Tilz is the deputy director of the Medical Center II of the University Hospital in Lübeck and professor of the invasive electrophysiology at the University Lübeck. He is committed to training in the field of “Invasive electrophysiology and cardiac rhythm implants”. Prof Roland Tilz trained at the Addenbrooks Hospital in Cambridge (UK), Bedford Hospital (UK), Klinikum Bayreuth and at the Asklepios Klinik St. Georg in Hamburg. 

 

View full profile

Comments

You must be to comment. If you are not registered, you can register here.